Stock Track | BIODLINK-B Soars 11.09% Intraday as WUXI XDC Takeover Becomes Effective

Stock Track

03/20

BIODLINK-B (01875) experienced a significant surge during intraday trading, with its stock price soaring 11.09%.

The sharp increase follows the announcement that WUXI XDC's cash offer to acquire BIODLINK has received valid acceptance for 60% of the company's equity, making the share offer officially effective. This controlling stake acquisition will enable WUXI XDC to enrich its project portfolio, expand its customer base, enhance production capacity allocation, and solidify its leading position in the global ADC CRDMO field.

According to Hong Kong Stock Exchange disclosures, WuXi XDC Cayman Inc. acquired 464 million ordinary shares of BIODLINK off-market at an average price of HK$4.0 per share in a transaction valued at approximately HK$1.855 billion, increasing its shareholding from 0.00% to 60.00%.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1109389510"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109389510\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109389510?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 10:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109389510","market":"sg","top_or_hot":-1,"title":"Stock Track | BIODLINK-B Soars 11.09% Intraday as WUXI XDC Takeover Becomes Effective","media":"Stock Track","content":"<p>BIODLINK-B (01875) experienced a significant surge during intraday trading, with its stock price soaring 11.09%.</p><p>The sharp increase follows the announcement that WUXI XDC's cash offer to acquire BIODLINK has received valid acceptance for 60% of the company's equity, making the share offer officially effective. This controlling stake acquisition will enable WUXI XDC to enrich its project portfolio, expand its customer base, enhance production capacity allocation, and solidify its leading position in the global ADC CRDMO field.</p><p>According to Hong Kong Stock Exchange disclosures, WuXi XDC Cayman Inc. acquired 464 million ordinary shares of BIODLINK off-market at an average price of HK$4.0 per share in a transaction valued at approximately HK$1.855 billion, increasing its shareholding from 0.00% to 60.00%.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BIODLINK-B Soars 11.09% Intraday as WUXI XDC Takeover Becomes Effective</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BIODLINK-B Soars 11.09% Intraday as WUXI XDC Takeover Becomes Effective\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-20 10:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIODLINK-B (01875) experienced a significant surge during intraday trading, with its stock price soaring 11.09%.</p><p>The sharp increase follows the announcement that WUXI XDC's cash offer to acquire BIODLINK has received valid acceptance for 60% of the company's equity, making the share offer officially effective. This controlling stake acquisition will enable WUXI XDC to enrich its project portfolio, expand its customer base, enhance production capacity allocation, and solidify its leading position in the global ADC CRDMO field.</p><p>According to Hong Kong Stock Exchange disclosures, WuXi XDC Cayman Inc. acquired 464 million ordinary shares of BIODLINK off-market at an average price of HK$4.0 per share in a transaction valued at approximately HK$1.855 billion, increasing its shareholding from 0.00% to 60.00%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01875","symbol_name":"东曜药业-B","start_time":0,"source_url":"","article_id":"1109389510","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109389510","pubTimestamp":1773972527,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BIODLINK-B (01875) experienced a significant surge during intraday trading, with its stock price soaring 11.09%.The sharp increase follows the announcement that WUXI XDC's cash offer to acquire...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01875":"东曜药业-B"},"translate_title":"个股追踪|BIODLINK-B盘中大涨11.09%，因药明XDC收购生效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01875":1},"content_text":"BIODLINK-B (01875) experienced a significant surge during intraday trading, with its stock price soaring 11.09%.The sharp increase follows the announcement that WUXI XDC's cash offer to acquire BIODLINK has received valid acceptance for 60% of the company's equity, making the share offer officially effective. This controlling stake acquisition will enable WUXI XDC to enrich its project portfolio, expand its customer base, enhance production capacity allocation, and solidify its leading position in the global ADC CRDMO field.According to Hong Kong Stock Exchange disclosures, WuXi XDC Cayman Inc. acquired 464 million ordinary shares of BIODLINK off-market at an average price of HK$4.0 per share in a transaction valued at approximately HK$1.855 billion, increasing its shareholding from 0.00% to 60.00%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}